Month: December 2017

Congresswoman Robin Kelly Marks World AIDS Day by Promoting Testing

Washington, DC—(ENEWSPF)—December 1, 2017 By: James Lewis [email protected] Today, Congresswoman Robin Kelly, chair of the Congressional Black Caucus Health Braintrust, released this statement marking World AIDS Day: “The AIDS epidemic is a public health crisis that affects every American community and communities across the globe. For decades, this terrible disease[Read More…]

FDA

FDA Approves First Biosimilar for Treatment of Certain Breast and Stomach Cancers

Silver Spring, Maryland—(ENEWSPF)—December 1, 2017 By: Angela Stark The U.S. Food and Drug Administration today approved Ogivri (trastuzumab-dkst) as a biosimilar to Herceptin (trastuzumab) for the treatment of patients with breast or metastatic stomach cancer (gastric or gastroesophageal junction adenocarcinoma) whose tumors overexpress the HER2 gene (HER2+). Ogivri is the[Read More…]

Lee Murdock and Blue Horizon

Lee Murdock and Blue Horizon at Edgar’s Place Coffeehouse on– Saturday, December 9

Park Forest, IL—(ENEWSPF)—December 1, 2017 By: Rosemary Piser Edgar’s Place Coffeehouse Proudly Presents: Lee Murdock and Blue Horizon on Saturday, December 9 at 7:30 p.m. Edgar’s Place is located at the Unitarian Universalist Community Church, 70 Sycamore Drive in Park Forest. In 2014, Lee Murdock formed his new band, Blue[Read More…]

Drug Policy Alliance

Drug Policy Alliance: Kellyanne Conway is the Wrong Person to Lead the White House’s Response to the Opioid Overdose Crisis

Administration Continues to Rely on Failed Criminal Justice Approaches to a Public Health Problem Washington, DC—(ENEWSPF)—December 1, 2017 By: Maria McFarland Sánchez-Moreno More than thirty days ago, President Trump declared a public health emergency on the opioid overdose crisis. In the month since the declaration, there has been little substantive[Read More…]

FoundationOne CDx (F1CDx)

FDA announces approval of First Breakthrough-designated Test to Detect Extensive Number of Cancer Biomarkers

Silver Spring, Maryland—(ENEWSPF)—December 1, 2017 By: Tara Rabin The U.S. Food and Drug Administration approved the FoundationOne CDx (F1CDx), the first breakthrough-designated, next generation sequencing (NGS)-based in vitro diagnostic (IVD) test that can detect genetic mutations in 324 genes and two genomic signatures in any solid tumor type. The Centers[Read More…]

ARCHIVES